Of note, a recent study challenges the prevailing view of PICT-1, suggesting that PICT-1 is a potentially oncogenic regulator of the MDM2-p53 pathway and acts as a tumor suppressor only under certain conditions, such as loss of p53 function [9]. Here, NOP53 is linked to neoplasm.